CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Return on equity 2021–2025
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27.7%FY2025 · since FY2021: -109.8% → -27.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -27.7% | -15.1 pp |
| FY2024 | -12.6% | +61.9 pp |
| FY2023 | -74.5% | +20.6 pp |
| FY2022 | -95.1% | +14.6 pp |
| FY2021 | -109.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CLOV financial trends
CLOV RevenueCLOV Net incomeCLOV Net marginCLOV Gross profitCLOV Gross marginCLOV Operating incomeCLOV Operating marginCLOV Operating cash flowCLOV Free cash flowCLOV Capital expendituresCLOV Stock buybacksCLOV Dividends paidCLOV Total assetsCLOV Total liabilitiesCLOV Shareholders’ equityCLOV overview →